Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Sara Vander Borght"'
Autor:
Mario Della Mura, Céline Clement, Maria P. Foschini, Sara Vander Borght, Lise Waumans, Peter Van Eyken, Esther Hauben, Machteld Keupers, Caroline Weltens, Ann Smeets, Ines Nevelsteen, Giuseppe Floris
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-9 (2023)
Abstract Background Mucoepidermoid carcinoma of the breast is a rare special type of salivary gland-like tumor of the breast, usually displaying triple-negative phenotype. To date, only 64 cases have been reported in the English literature. Herein, w
Externí odkaz:
https://doaj.org/article/0e2363cf20e543b5a9a28f74c56bbd37
Autor:
Rafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, Lien Spans, Raphael Sciot, Patrick Schöffski, Daphne Hompes, Friedl Sinnaeve, Hazem Wafa, Marleen Renard, Mari FCM van den Hout, Astrid Vernemmen, Louis Libbrecht, An‐Katrien De Roo, Filomena Mazzeo, Cédric van Marcke, Karen Deraedt, Claire Bourgain, Isabelle Vanden Bempt
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract The identification of gene fusions has become an integral part of soft tissue and bone tumour diagnosis. We investigated the added value of targeted RNA‐based sequencing (targeted RNA‐seq, Archer FusionPlex) to our current molecular diag
Externí odkaz:
https://doaj.org/article/a4e531c2073947398417e6e0aa6c457f
Autor:
Kelly Dufraing, Kaat Van Casteren, Joke Breyne, Nicky D’Haene, Claude Van Campenhout, Sara Vander Borght, Karen Zwaenepoel, Etienne Rouleau, Ed Schuuring, Jan von der Thüsen, Elisabeth Dequeker
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-20 (2022)
Abstract Background For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the laboratories adapt test
Externí odkaz:
https://doaj.org/article/005a0612409243a0b303ce9ae8fd9332
Autor:
Jasper Victoor, Claire Bourgain, Sara Vander Borght, Isabelle Vanden Bempt, Carine De Rop, Giuseppe Floris
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Background We report an unusual case of low-grade fibromatosis-like metaplastic carcinoma (LG-FLMC) of the breast. This exceedingly rare epithelial breast malignancy has been reported only 68 times in the past 20 years, and is classified as
Externí odkaz:
https://doaj.org/article/bf472bdf7a314034b8c0496e90d37ab2
Autor:
Laurence Slembrouck, Lauren Darrigues, Cecile Laurent, Lorenza Mittempergher, Leonie JMJ Delahaye, Isabelle Vanden Bempt, Sara Vander Borght, Liesbet Vliegen, Petra Sintubin, Virginie Raynal, Mylene Bohec, Cécile Reyes, Audrey Rapinat, Céline Helsmoortel, Lynn Jongen, Griet Hoste, Patrick Neven, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, Anne Vincent Salomon, Enora Laas Faron, Timothé Cynober, David Gentien, Sylvain Baulande, Mireille HJ Snel, Anke T Witteveen, Sari Neijenhuis, Annuska M Glas, Fabien Reyal, Giuseppe Floris
Publikováno v:
Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)
A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subt
Externí odkaz:
https://doaj.org/article/7dd90bdd8d2b401cbc180de9d3769d13
Autor:
Enrico Radaelli, Els Hermans, Lorna Omodho, Annick Francis, Sara Vander Borght, Jean-Christophe Marine, Joost van den Oord, Frédéric Amant
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124974 (2015)
Patient-derived tumor xenograft (PDTX) approach is nowadays considered a reliable preclinical model to study in vivo cancer biology and therapeutic response. NOD scid and Il2rg-deficient mice represent the "gold standard" host for the generation of P
Externí odkaz:
https://doaj.org/article/b25ad4c198764e30a714a0e1b857842d
Autor:
Barbara Sigala, Chad McKee, Junpei Soeda, Valerio Pazienza, Maelle Morgan, Ching-I Lin, Clare Selden, Sara Vander Borght, Gianluigi Mazzoccoli, Tania Roskams, Manlio Vinciguerra, Jude A Oben
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e72928 (2013)
Sympathetic nervous system (SNS) signalling regulates murine hepatic fibrogenesis through effects on hepatic stellate cells (HSC), and obesity-related hypertension with SNS activation accelerates progression of non-alcoholic fatty liver disease (NAFL
Externí odkaz:
https://doaj.org/article/fce5e304dd4642aba3443a3f77fe6a80
Autor:
Tatjana Geukens, Maxim De Schepper, François Richard, Marion Maetens, Karen Van Baelen, Amena Mahdami, Ha-Linh Nguyen, Edoardo Isnaldi, Sophia Leduc, Anirudh Pabba, Imane Bachir, Freya Mertens, Sara Vander Borght, Ann Smeets, Ines Nevelsteen, Kevin Punie, Patrick Neven, Hans Wildiers, Wouter Van Den Bogaert, Giuseppe Floris, Christine Desmedt
Publikováno v:
Cancer Research. 83:HER2-16
Background. Trastuzumab deruxtecan (T-DXd) has shown promising activity in patients with HER2-low metastatic breast cancer. As the HER2-status can vary between the primary and its corresponding metastases, treatment decisions should ideally be based
Autor:
Elena Vigliar, Eugenio Gautiero, Annalisa Altimari, Reinhard Büttner, Birgit Weynand, Carlos E. de Andrea, Philippe Vielh, Francesco Pepe, Claudio Bellevicine, Paul Hofman, Miguel Angel Molina Vila, Rossella Bruno, Fernando Schmitt, Véronique Hofman, Giancarlo Troncone, Francesc Tresserra, Luis Cirnes, Rafael Rosell, Ruth Román, Sabine Merkelbach-Bruse, David Gentien, Fabio Pagni, Dario de Biase, Catherine I. Dumur, Giulia Anna Carmen Vita, Kajsa Ericson Lindquist, Gabriella Fontanini, Sinchita Roy-Chowdhuri, Janna Siemanowski, Maria D. Lozano, Clara Mayo-de-las-Casas, Pasquale Pisapia, Sara Vander Borght, Antonino Iaccarino, Hans Brunnström, Umberto Malapelle, Giovanni Tallini
AimsGene fusions assays are key for personalised treatments of advanced human cancers. Their implementation on cytological material requires a preliminary validation that may make use of cell line slides mimicking cytological samples. In this interna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::322d515ac277c6c37552bcb9c36ae149
http://hdl.handle.net/10281/324997
http://hdl.handle.net/10281/324997
Autor:
Karen Zwaenepoel, Kaat Van Casteren, Joke Breyne, Etienne Rouleau, Elisabeth Dequeker, Kelly Dufraing, Nicky D'Haene, Claude Van Campenhout, Ed Schuuring, Jan H. von der Thüsen, Sara Vander Borght
Publikováno v:
BMC Cancer, 22:736. BMC
BMC cancer
BMC Cancer, 22(1):736. BioMed Central Ltd.
BMC cancer
BMC Cancer, 22(1):736. BioMed Central Ltd.
Background For patients with non-small cell lung cancer (NSCLC), targeted therapies are becoming part of the standard treatment. It is of question which information the clinicians provide on test requests and how the laboratories adapt test conclusio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d095f7c53f313d87f20504da8a0a8b0
https://research.rug.nl/en/publications/baa504ca-1487-4d15-989f-fc0641160a64
https://research.rug.nl/en/publications/baa504ca-1487-4d15-989f-fc0641160a64